Showing results (181-190 of 302) with videos related to
Sort By:
Pageof 31
Blood Advances|January 11, 2022
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphomaLoretta J Nastoupil, Collin K Chin, Jason R Westin, et al.Blood Cancer Discovery|June 10, 2022
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II ExpressionGuangchun Han, Qing Deng, Mario L Marques-Piubelli, et al.American Journal of Hematology|February 14, 2020
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphomaJohn Timmerman, Charles Herbaux, Vincent Ribrag, et al.Nature Communications|August 12, 2017
Absence of Grail promotes CD8+ T cell anti-tumour activityCara Haymaker, Yi Yang, Junmei Wang, et al.British Journal of Haematology|March 18, 2020
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphomaNathan H Fowler, Loretta Nastoupil, Sven De Vos, et al.Blood|June 9, 2022
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphomaPaola Ghione, M Lia Palomba, Anik R Patel, et al.British Journal of Haematology|March 25, 2017
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized StudyLoretta J Nastoupil, Peter McLaughlin, Lei Feng, et al.Blood|February 12, 2025
Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 studyJulio C Chavez, Michael Dickinson, Javier Munoz, et al.Haematologica|January 29, 2016
Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemiaPaolo Strati, Joon H Uhm, Timothy J Kaufmann, et al.Journal of Cutaneous Pathology|March 31, 2026
A Rare Case of Cutaneous Crystal-Storing Histiocytosis With Kappa Light Chain Restriction and Unusual BCL6 ExpressionLiangli Wang, Jonathan L Curry, Julia Dai, et al.Pageof 31